X

ASCPT News, August 2020

Author: [AUTHOR] Published on 8/6/2020 5:00:00 AM


ASCPT is Now Accepting Scientific Abstracts for Consideration
Submit your latest science in abstract form for presentation during the ASCPT 2021 Annual Meeting and put your science in front of a broad range of experts in clinical pharmacology and translational science.

ASCPT is now accepting scientific abstracts for the ASCPT 2021 Annual Meeting! ASCPT is calling for provocative and engaging science and novel and unique presentation methods such as Poster 2.0 for our next conference. For further information, visit the Call for Abstracts & Abstract Guidelines

Deadline for submission: Thursday, September 10, 2020, 4:00 PM ET

Questions about abstract criteria and submission can be directed to Diana Tsuji at diana@ascpt.org or Nicole Rockman at nicole@ascpt.org.

Listen to ASCPT’s Newest Podcast: ASCPT Catalyst 
ASCPT Catalyst podcast episodes are tackling topics such as COVID-19, the gender gap, racial inequity, volunteer opportunities, and more! 

Visit ASCPT Catalyst to catch up on our all published episodes!
  • Episode 0: Welcome to ASCPT Catalyst - featuring Susan Abdel-Rahman, PharmD, ASCPT President & Sharon Swan, FASAE, CAE, ASCPT CEO
  • Episode 1: Diversity at Scientific Meetings - featuring Kathryn Momary, PharmD, SPC Chair
  • Episode 2: Racial Inequality in Academic Medicine - featuring Tamorah Lewis, MD, Board Member
  • Episode 3: Drug Development for COVID-19 - A Clinical Pharmacology Perspective Webinar Q&A - featuring Matthew Rizk, PhD, ASCPT Board of Directors, Su-Young Choi, PhD, & Vikram Arya, PhD
  • Episode 4: Meet the Career Development Committee - featuring Sonya Tang Girdwood, MD, PhD & Jonathan Wagner, DO
  • Episode 5: ASCPT Career Center Micro-Recruitment Session with Certara Webinar Q&A - featuring Lisa Infelise, ASCPT Senior Director of Member Services, Julie Bullock, Vice President, Integrated Drug Development, & Emily Cox, Director, Talent Acquisition from Certara
  • Episode 6: The Complexity of Developing Therapeutics for COVID-19 Webinar Q&A - featuring Gauri Rao, PharmD & Prabha Fernandes, PhD
  • Episode 7: Network and Community Volunteerism - featuring Ryan Funk, PhD, PharmD & Lisa Infelise

Please submit your feedback, ideas, and comments for new podcast episodes via email meetings@ascpt.org or call (703) 836-6981, ext.108 or 109.

 

Submit Your Interest in a New ASCPT Rare Diseases Community
ASCPT is proud to build on member needs, suggestions, and scientific interest areas! Recently, a member approached ASCPT with a request to launch a new Community within the Translational & Precision Medicine (TPM) – a Rare Diseases Community.

ASCPT requires the support of 30 interested members to launch a new Community. Please take a moment to fill out this short interest form if you would like to provide your endorsement and involvement in this new Community!

Please contact members@ascpt.org if you have questions about ASCPT’s Networks and Communities or desire to become further involved with this initiative. 

The ASCPT Journal Family Welcomes Three New Editors
Clinical Pharmacology & Therapeutics and Clinical and Translational Science have welcomed new associate editors to their editorial teams.

Walter Kraft, MD, and Peter Honig, MD, have both joined the CPT team. Walter is an internist and clinical pharmacologist, currently serving as director of the Thomas Jefferson University (Jefferson) Clinical Research Unit. He is also interested in the development of novel therapeutics in neonatal abstinence syndrome and is the co-primary investigator on the National Institute of General Medical Sciences funded fellowship program in clinical pharmacology at Jefferson. Additionally, he directs the Jefferson Office of Human Research, which oversees the protection of all human subjects for the organization. Walter has held leadership positions in a number of national professional organizations including a stint as treasurer for ASCPT and as a board member on the American Board of Clinical Pharmacology. Presently, he sits on the US Food and Drug Administration (FDA) Advisory Committee for Clinical Pharmacology as well as maintaining a clinical practice in vascular medicine and the treatment of complex venous and arterial thrombotic diseases. 

Returning to the CPT editorial team, Peter is responsible for worldwide safety and regulatory affairs for Pfizer, a position he has held since 2015. Beginning in 2019, he also oversees Pfizer’s China and Japan drug development organizations. (Previous industry positions include time at AstraZeneca and Merck Research Laboratories.) Before joining the industry, Peter founded and was the first Director for the Office of Drug Safety in the US FDA Center for Drug Evaluation and Research (CDER). During his time at CDER he co-authored many FDA guidance documents and received numerous awards and citations. Along with a term as associate editor for CPT, he also served ASCPT as President, Vice President, Member of the Board of Directors, and Chair of the section on Pharmacoepidemiology, Drug Safety, and Outcomes Research. Since 2003, Peter has been the PhRMA representative for the International Conference on Harmonization (ICH) Steering Committee and is the past co-chair of the ICH Global Cooperation Group. He is a member of the Executive Steering Committee of the FNIH Biomarkers Consortium and a past member of the Science Moving Forward Subcommittee for the FDA Science Board, which examines the FDA’s regulatory science capabilities. 

CTS welcomed Ronda Rippley, PhD, who has 24 years of experience as a quantitative scientist focusing on clinical and translational pharmacology within the pharmaceutical industry. Currently, Ronda is Vice President and Head of Clinical Pharmacology at Boston Pharmaceuticals where her work focuses on reducing translational risk and increasing the probability of achieving successful proof of concept. Prior affiliations include Merck, Amgen, and Regeneron. Within ASCPT, she was Vice-Chair of the Biomarkers and Translational Tools community and has contributed on several ad hoc committees, including the Section Futures Task Force and the Strategic Plan Tactical Task Force. 

Walter, Peter, and Ronda round out two already robust editorial teams, bringing their expertise and thoughtful feedback to ASCPT’s Journal Family.  

Interested in submitting to one of the ASCPT journals? Questions about submission can be sent to alethea@ascpt.org or alaina@ascpt.org.

 

Wanted: Innovative Strategic Thinkers
Are you looking to take the next step in your involvement in ASCPT? ASCPT is seeking committed strategic thinkers looking to help drive the future of the Society.

Nominations for the ASCPT Board of Directors are now open. ASCPT is accepting nominations for President-Elect and two (2) At-Large Members of the Board of Directors. Submit your nomination form by September 14, 2020, to be considered as a candidate for the Board.  

If you have any questions about the nomination process contact megan@ascpt.org

NIH Webinar on the MOSAIC Program
The National Institutes of Health will be holding a webinar for the NIH Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) on Tuesday, August 18 at 1 PM ET/10 AM PT.

The MOSAIC program is designed to facilitate the transition of promising postdoctoral researchers from diverse backgrounds, for example postdocs from groups underrepresented in the biomedical research workforce at the faculty level, into independent faculty careers in research-intensive institutions. The program has two components: a postdoctoral career transition award (K99/R00), and a research education cooperative agreement (UE5).

There are currently 15 ICs participating in the MOSAIC K99/R00 program (NIGMS, NIBIB, NINR, NIMHD, NHGRI, NIA, NLM, NIMH, NIDA, NIAAA, NHLBI, NIEHS, NIDCD, NIDCR and NCCIH).  NIH accepts applications for this award three times per year (similar to the parent K99), and the next application receipt date is October 12, 2020.  

In addition to the postdoctoral transition award, MOSAIC scholars become members of scientific cohorts and participate in mentoring, networking, and professional development activities coordinated by MOSAIC UE5 awardees.  The initial MOSAIC UE5 Awardees are The American Society for Cell Biology (ASCB), The American Society for Biochemistry and Molecular Biology (ASBMB), and The Association of American Medical Colleges (AAMC).  The NIMH, NHBLI, NLM, and NCCIH will accept applications for the MOSAIC UE5 program for the November 2, 2020 deadline. If your organization is interested in partnering with NIH on this effort I encourage you to reach out to the scientific/research contacts listed in the FOA to learn more (NIGMS does not intend to fund additional MOSAIC UE5s).

The informational webinar will be on Tuesday, August 18 at 1 PM ET/10 AM PT. You can find the login  information on the NIGMS Meetings Webpage.  You can read more about the MOSAIC program in a recent post on the NIGMS Feedback Loop Blog, as well as answers see answers to Frequently Asked Questions.

 

Let the ASCPT Career Center Facilitate Your Employer and Employment Success
Are you looking to take your career to the next level? Are you curious about current opportunities and your professional development? The ASCPT Career Center is a must-have resource for you! 

In addition to providing targeted positions from field leaders, our online Career Center offers many tools and resources to help with your job search during these challenging times, including quality job posts, anonymous CV posting, and a centralized Job Seeker account to help you manage your job alerts and  CVs. 

If you are an employer looking for qualified talent for an open position, we offer special products and pricing for members for online basic, enhanced, premium, and fellowship postings; literature board options, banner ads, and more! 

Whether you are looking to maximize your recruitment dollars or if a new career is on your horizon, the ASCPT Career Center is a valuable resource that connects employers with qualified candidates and supports recruitment and employment success. Have questions, need assistance, or would like more information about how to host your own session? Reach out to lia@ascpt.org.

 

ASCPT Welcomes the following New Members to the Society: 

Samantha Bailey, PharmD
Nadia Bamfo, PharmD
Amer Bektas, BSc
Monica Bennett, BS
Sujit Biswas, MSc
Jieyun Cao, PhD
Wilson Chen, BSc
S.Y. Amy Cheung, PhD
Kyu Yeon Choe, BS
Lauren Cirrincione, PharmD
Adam Closmore, BSc
Isaac Cohen, PharmD
Madison Crutcher, MD
Nicole Del Toro-Pagan, PharmD
Ahmed El-Sherbeni, PhD
Leila Esmaeili, PharmD
Tereasa Fontanese, BA
Jennifer Ford, PhD
Michael Fusco, PharmD
Jason Giles, BS, MS
Kadee Gullickson, BS
Jafar Hasbullah, BS
Victoria Helfer
Kayeleigh Higgerson, DO
Dustin Huynh, BS
Sherry Ibrahim, BS
Elena Izmailova, PhD
Saeim Jeong, MD
Xuemin Jiang, PhD
Lorne Jordan, PhD
Hyun Chul Kim, RPh
Kevan King, BS, MS
Kirby Knutson, PharmD
Madeline Kreider, PharmD
Janelle Lennie, MS
Timothy Lex, PhD
Hye Lim Lim, PharmD
Ana Lopez Medina, BS
Sally Luvsantseren, PharmD
Julia Macente
Yewon Park, BCh
Keng Hee Peh, PharmD
Erica Ridolfi, BA
Stephanie Rolsma, MD, PhD
Elizabeth Rowe, PhD
Siddhee Sahasrabudhe, BS, MS
Narjes Saheb Sharif-Askari, PharmD, PhD
Engie Salama, PharmD
Chitra Saran, MS
Leanne Saville, PharmD
Preetika Sharma-Huynh, PharmD
Mikhail Sinelnikov, MD
Heidi Steiner, BSc, MS
Steven Sun, BS
Allie Symonds, PharmD
Britnee Taylor, BS
Elizabeth, Thompson, BMD
Joyce van der Heijden, MSc
Tajhia Whigham, PharmD
Kevin Yan, RPh
Yuqing (Anne) Yang, PhD

 

print
Sort by:
Photo Gallery
Recent News
  • Intranasal Insulin: Emerging Treatment to Reduce Neurological Insult?
    April 30, 2025
  • Understanding the Pharmacokinetics of Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Using Physiologically Based Pharmacokinetic Models
    April 16, 2025
  • ASCPT Adviser: April 2025
    April 03, 2025
Contact Us